by GlobeNewsWire | Dec 8, 2017 | Globe Newswire
Fiscal Year Reported Net Income – $1.26 millionFiscal Year Adjusted Net Income – $1.21 million, an increase of $417,333Comparable 52-week attendance revenues increase $1.23 million or 25.0%Double-digit percentage growth in attendance based net sales in 12...
by GlobeNewsWire | Dec 8, 2017 | Globe Newswire
CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE:ODC), producer and marketer of sorbent mineral products supplying pet care, animal health, fluids purification, agricultural ingredient, sports field, industrial and automotive...
by GlobeNewsWire | Dec 8, 2017 | Globe Newswire
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) — Focus Graphite Inc. (TSX-V:FMS) (OTCQX:FCSMF) (FSE:FKC) (“Focus” or the “Company”) is pleased to provide an update...
by GlobeNewsWire | Dec 8, 2017 | Globe Newswire
EMERYVILLE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted 64 new employees the option to purchase an aggregate of 77,550 shares of...
by GlobeNewsWire | Dec 8, 2017 | Globe Newswire
Last three patients enrolled into the Phase II COBALT trial on the new dosing regimen (45 mg per Day) saw a more rapid decline in LDH than those in the original dosing regimen. The Day 28 Endpoint was less than or equal to 1.5 x ULN for all three patients. The new...